Surface Oncology Inc SURF:NASDAQ

Last Price$1.76NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/24/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$1.67 (2)
Ask (Size)$1.86 (2)
Day Low / HighN/A - N/A
Volume45.00

Surface Oncology Gets US FDA Clearance for Human Clinical Trial of Potential Anti-Tumor Therapy

8:39AM ET 12/01/2021 MT Newswires
Surface Oncology (SURF) said Wednesday the US Food and Drug Administration has cleared the company's investigational new drug application for its GSK4381562, a fully human IgG1 antibody, to proceed to a first-in-human clinical trial.

The investigational antibody promotes the activation of both natural killer cells and T cells, with the potential to elicit a strong anti-tumor response and promote immunological memory, according to a statement.

Surface Oncology will receive a $30 million milestone payment at the start of the first phase 1 study for GSK4381562. The company is also eligible to receive an additional $700 million in future milestone payments, as well as tiered royalties on global net sales.

Price: 5.89, Change: +0.12, Percent Change: +0.02